Bone Medical Limited Stock Australian S.E.
Equities
AU0000BNEDC4
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- AUD | - |
Sales 2024 * | 800M 532M | Sales 2025 * | 30.5B 20.29B | Capitalization | 457M 304M |
---|---|---|---|---|---|
Net income 2024 * | -11.7B -7.78B | Net income 2025 * | 9.3B 6.19B | EV / Sales 2024 * | -11.4 x |
Net cash position 2024 * | 9.6B 6.39B | Net cash position 2025 * | 2.3B 1.53B | EV / Sales 2025 * | -0.06 x |
P/E ratio 2024 * |
-29
x | P/E ratio 2025 * |
29
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 85.28% |
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 19-04-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
Chief Tech/Sci/R&D Officer | 68 | 21-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 19-02-20 |
Henry Bosch
BRD | Director/Board Member | - | 16-06-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
1st Jan change | Capi. | |
---|---|---|
+16.17% | 79.16B | |
+8.99% | 8.72B | |
-16.43% | 4.79B | |
+48.34% | 4.62B | |
+2.91% | 3.82B | |
+14.51% | 2.33B | |
-26.94% | 2.2B | |
+16.55% | 2.1B | |
-36.25% | 2.04B |